Operating Income for Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's current operating income (TTM) is $1.61B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$1.61B
YoY change
+19.1%
5Y CAGR
-4.0%
Peak year (2021)
$2.38B
Cumulative operating income
$30.62B
Operating Income history chart for Quest Diagnostics (DGX) from 1996 to 2025
Operating Income history table for Quest Diagnostics (DGX) from 1996 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $1.60B | +19.1% | ||
| 2024 | $1.35B | +6.7% | ||
| 2023 | $1.26B | -11.6% | ||
| 2022 | $1.43B | -40.0% | ||
| 2021 | $2.38B | +20.8% | ||
| 2020 | $1.97B | +60.1% | ||
| 2019 | $1.23B | +11.8% | ||
| 2018 | $1.10B | -5.5% | ||
| 2017 | $1.17B | -8.8% | ||
| 2016 | $1.28B | -8.7% | ||
| 2015 | $1.40B | +42.3% | ||
| 2014 | $983.00M | -33.4% | ||
| 2013 | $1.48B | +22.8% | ||
| 2012 | $1.20B | +20.7% | ||
| 2011 | $995.00M | -23.2% | ||
| 2010 | $1.30B | -4.7% | ||
| 2009 | $1.36B | +11.2% | ||
| 2008 | $1.22B | +12.0% | ||
| 2007 | $1.09B | -3.3% | ||
| 2006 | $1.13B | +16.5% | ||
| 2005 | $968.11M | +7.4% | ||
| 2004 | $901.44M | +13.3% | ||
| 2003 | $795.43M | +34.3% | ||
| 2002 | $592.45M | +44.0% | ||
| 2001 | $411.39M | +29.4% | ||
| 2000 | $317.82M | +109.1% | ||
| 1999 | $152.00M | +61.2% | ||
| 1998 | $94.30M | +26.2% | ||
| 1997 | $74.70M | -112.4% | ||
| 1996 | -$601.28M | — |
Operating Income values are taken from Quest Diagnostics's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Quest Diagnostics (DGX) operating income totalled $1.60B – grew 19.1% year-over-year.
Through 2020–2025 (5 years), Quest Diagnostics operating income delivered a -4.0% annualised rate; sustaining 2 straight years of year-over-year growth.
Between 2021 and 2025, Quest Diagnostics operating income plunged 32.7%, falling from $2.38B to $1.60B.
The highest annual operating income of $2.38B was reported in 2021. The lowest in the available history was -$601.28M in 1996.
Within Healthcare, Quest Diagnostics (DGX) ranks 9th among 8 peers we track. The peer median for operating income is $22.84B.
Quest Diagnostics Operating Income by Year
Quest Diagnostics Operating Income 2025: $1.60B
Quest Diagnostics operating income in 2025 was $1.60B, grew 19.1% from 2024.
Quest Diagnostics Operating Income 2024: $1.35B
Quest Diagnostics operating income in 2024 was $1.35B, grew 6.7% from 2023.
Quest Diagnostics Operating Income 2023: $1.26B
Quest Diagnostics operating income in 2023 was $1.26B, declined 11.6% below 2022.
Quest Diagnostics Operating Income 2022: $1.43B
Quest Diagnostics operating income in 2022 was $1.43B, plunged 40.0% below 2021.
Quest Diagnostics Operating Income 2021: $2.38B
Quest Diagnostics operating income in 2021 was $2.38B.
See more financial history for Quest Diagnostics (DGX).
Sector peers — Operating Income
Companies in the same sector as Quest Diagnostics, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Quest Diagnostics's operating income?
- Latest reported operating income for Quest Diagnostics (DGX) is $1.61B (period ending March 31, 2026).
How has Quest Diagnostics operating income changed year-over-year?
- Quest Diagnostics (DGX) operating income changed +19.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Quest Diagnostics operating income?
- Quest Diagnostics (DGX) operating income compound annual growth rate is -4.0% over the most recent 5 years available.
When did Quest Diagnostics operating income hit its highest annual value?
- Quest Diagnostics operating income reached its highest annual value of $2.38B in 2021.
What was Quest Diagnostics operating income in 2024?
- Quest Diagnostics (DGX) operating income in 2024 was $1.35B.
What was Quest Diagnostics operating income in 2025?
- Quest Diagnostics (DGX) operating income in 2025 was $1.60B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DGX Overview
Company profile, financial tools, and key metrics
DGX Revenue Counter
Earns $357.62 every second. See per minute, hour, and day.
DGX Earnings Counter
Earns $32.47 per second net profit. See per minute, hour, and day.
DGX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
DGX What If Invested
What if you had invested $1,000? See historical returns from any date.
DGX How It Makes Money
Discover visual breakdown of $11.28B in revenue — where it comes from and where it goes.
DGX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DGX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DGX Daily Price Character
Steady · 50.6% historical win rate (green days). Streaks & record days.
DGX Buybacks
2.09% TTM buyback yield. Shareholder yield & SBC comparison.
DGX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
DGX Dividend Profile
Yield: 1.72%. Safety: 5/8. See full history.
DGX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DGX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.